30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Datum Orthobiologics to Develop New Biomaterials -

Datum Orthobiologics as been founded and is raising funds to develop bio-programmable biomaterials with musculoskeletal applications. The company will first focus on bone grafts for use in fracture healing and spinal fusion. Datum Orthobiologics benefits from patented GLYMATRIX® technology, which is based on 25+ years of R&D and postmarketing research as well as intellectual property acquired from Johnson & Johnson. (Datum Biotech and Datum Orthobiologics, 4/24/18)